Work

NICE’s rejection of pembrolizumab for platinum-refractory urothelial carcinoma: is there a greater good?

Year: 2020

Type: other

Source: Nature Reviews Urology

DOI: 10.1038/s41585-020-0357-1

Authors: Shilpa Gupta, Ashish M. Kamat

Institutions: Cleveland Clinic, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3040199835

Cites: 13

Cited by: 5

Related to: 10